Cancer News and Research

RSS
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Fiber optical nanomechanical probe can measure in vivo biomechanical properties of tissue, single cell

Fiber optical nanomechanical probe can measure in vivo biomechanical properties of tissue, single cell

Prolonged alcohol use and its detrimental effects on blood protein snapshot

Prolonged alcohol use and its detrimental effects on blood protein snapshot

Importance of epigenetic regulation in the recovery of T cells

Importance of epigenetic regulation in the recovery of T cells

Researchers pioneer a new approach to study mosquito's DNA

Researchers pioneer a new approach to study mosquito's DNA

Researchers address new quantitative approaches to better define cancer epigenetic landscape

Researchers address new quantitative approaches to better define cancer epigenetic landscape

Combination of two types of immune cells helps predict response to cancer immunotherapy

Combination of two types of immune cells helps predict response to cancer immunotherapy

U.S. people show interest in using genetic technologies to improve offspring education

U.S. people show interest in using genetic technologies to improve offspring education

Protein-rich droplets in cells linked to many unresolved diseases

Protein-rich droplets in cells linked to many unresolved diseases

Telomeres, mitochondria, and inflammation: Working in synergy to fight cancer

Telomeres, mitochondria, and inflammation: Working in synergy to fight cancer

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Novel combination therapy shows promise in acute myeloid leukemia

Novel combination therapy shows promise in acute myeloid leukemia

Protein that facilitates cancer-causing viruses dodge the immune system

Protein that facilitates cancer-causing viruses dodge the immune system

Innovative cancer therapy options with new cell death mechanism

Innovative cancer therapy options with new cell death mechanism

Study elucidates the structure of centromeric region in chicken cells

Study elucidates the structure of centromeric region in chicken cells

Newly discovered gene signature accurately predicts the functioning of P53 variants

Newly discovered gene signature accurately predicts the functioning of P53 variants

Treating ovarian cancer with immunotherapy involving CAR T cells

Treating ovarian cancer with immunotherapy involving CAR T cells

Structure of amyloid fibers formed by the protein hnRNPDL-2 determined

Structure of amyloid fibers formed by the protein hnRNPDL-2 determined

Researchers use AI to identify genes that are critical to a cancer cell’s survival

Researchers use AI to identify genes that are critical to a cancer cell’s survival

CAR T-cell therapy effective in mice with ovarian cancer

CAR T-cell therapy effective in mice with ovarian cancer

Study sheds light on why lung tumors do not respond well to immunotherapy

Study sheds light on why lung tumors do not respond well to immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.